KPTI

Karyopharm Therapeutics Inc. - Common Stock (KPTI)

About Karyopharm Therapeutics Inc. - Common Stock (KPTI)

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Details

Daily high

$4.74

Daily low

$4.34

Price at open

$4.70

52 Week High

$17.40

52 Week Low

$3.51

Market cap

39.7M

Dividend yield

0.00%

Volume

70,016

Avg. volume

83,190

P/E ratio

-.35

Karyopharm Therapeutics Inc. - Common Stock News